Results for tag: "Retinitis Drug"

The Retinitis Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye diseases. Retinitis drugs are used to treat retinitis, a condition that causes inflammation of the retina, which can lead to vision loss. These drugs are typically administered as injections, and can be used to reduce inflammation and prevent further damage to the retina. Common retinitis drugs include corticosteroids, antivirals, and immunosuppressants. The Retinitis Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Novartis, Pfizer, Allergan, and Regeneron. Other companies, such as Genentech, Roche, and Bayer, also offer retinitis drugs. Show Less Read more